Tag Archives: united-states
Understanding XLE: Looking Back And Going Forward
XLE has outperformed oil thus far this year. This does not mean it will outperform oil in a bull market. Diversification is a strength to prevent weakness, but also limits potential investment upside. With oil prices nearing the $40 a barrel mark there are many enterprising investors hypothesizing that now is the time to hop into an Energy sector ETF and enjoy the ride if oil prices recover. Surely it makes sense that the Energy Select Sector SPDR ETF (NYSEARCA: XLE ) would increase along with oil prices; conventional wisdom would have an investor believe that with oil prices so low energy sector ETFs have massive upside. However, examining a few charts tells a far different story, that the very same diversification that limits its downside also restricts the fund’s upside. It has been noted elsewhere on the site that the diversification of the ETF (as it sets out to track the Energy industry as a whole) allows it to outperform the The United States Oil ETF (NYSEARCA: USO ). While this may be true over the past five years, in which XLE has gained 30% despite USO dropping over 58% (all figures at time of writing), it is a fundamentally misguided belief to assume this would occur in an oil recovery. Because, as the chart below shows, the 5 year comparison began at a high-point in the commodity cycle, meaning USO could only really remain flat and then fall drastically in accordance with the WTI collapse; conversely, during a generally flat market with high oil prices the Energy ETF had room to grow along with the Earnings of the companies it tracked. (click to enlarge) What is worth noting, however, is that XLE has not seen nearly as severely a sell off as Crude Oil or the ETFs that track it. Could this mean XLE is the perfect instrument for every portfolio ? Just looking at the five-year chart and other analysis on the fund would have you believe it is, but it makes the crucial mistake of not recognizing how the companies composing XLE will perform in the future, and how its composition limits returns the same way it limits downside. Before proceeding, I highly recommend an investor read Jonathan Prather’s article on XLE, as it does a fantastic job of depicting the fund’s correlation with the index it tracks and why it is a better investment than its peers. There is one issue to be noted with the article, however, and that is with the assertion that “It is clear that XLE is more capable of mitigating its downside in a weak environment whilst maximizing returns in a bull market. I believe companies are able to develop strategies that allow for protection from fluctuations in price.” From March 15 to May 28 USO drastically outperformed XLE in a bull market; it is in a rising commodity price environment that USO will dominate XLE, thus any investor interested in an ETF to play the recovery could see higher returns in USO, not XLE. As Prather noted, though, XLE offers more downside protection, or at least has thus far. Now, to understand why XLE has managed the downturn without tumbling nearly as far as oil itself we need to examine its holdings and analyze what they might mean for the future — in both a low oil pricing environment and in a rising one, before judging whether or not to invest. How XLE Has Thus Far Outperformed Oil In the case of a severe downturn it is the diversification of the fund that gives it its strength, as noted above. The mechanics behind this result from the companies in the downstream performing exceptionally well and benefiting from lower oil prices, thus the share price gain from the refining stocks — which comprise about 12% of the overall fund — has mitigated the more drastic falls in some of the Exploration and Production companies. The chart below depicts just how well refiners have performed, demonstrating that their appreciation has helped keep XLE from sinking to the same depths as USO: (click to enlarge) But because of this paradigm the idea that the refiners will grow XLE is slightly misguided; that is, because they are only a portion of the pie they will not propel the entire fund in the green if other components continue to falter. Overall, refiners may be loss limiting in a low-oil price environment, but they are not gain-leading. An investor operating under the belief that oil prices are to remain lower for longer best not seek XLE for its refiners, a pure refiner-play would, of course, be the better bet. Moreover, while some of the fund’s Offshore Drillers and Shale Producers have particularly felt the pain of oil’s fall, many producers have had their costs reduced or managed the commodities market well enough to outperform the general oil market (in the case of Cabot Oil and Gas and EOG Resources , for example). The below chart depicts how some of the E&Ps have performed over the past six months, with USO in bold: (click to enlarge) Clearly many of the fund’s E&Ps, which account for around 32% of total fund investments, have exceeded oil’s own performance, as — for many — reduced costs, focuses on core acreage, and advances in technology have led to higher returns for this resilient group. Of course, an investor would have been far worse handpicking an E&P over XLE, as some such as Chesapeake Energy (NYSE: CHK ) — now down 63% over the past six months — have underperformed even oil itself. The same paradigm holds true for the fund’s other groups, with ExxonMobil (NYSE: XOM ) down just 15% over the past six months (versus 25% for USO); moreover, Williams Companies (NYSE: WMB ) is 6% in the green over the same time period due partially to their large natural gas exposure. Many of the services companies, such as Schlumberger (NYSE: SLB ) and Halliburton (NYSE: HAL ), have shed less than 10% of their value since January as their businesses are not nearly as oil-dependent as the E&Ps. Due to its diversification across sectors that have varying degrees of oil dependency — and across companies within these sectors — XLE’s downside has been limited enough to prevent severe losses. However, before making any investment decision we must understand how this knowledge will manifest itself in future price movements. Going Forward What happens if oil truly remains lower for longer? For USO, that means the downside is likely limited to another 5 to 10% if we see $35 a barrel oil, and if oil stagnates around $40 a barrel USO is unlikely to lose more than 4% of its value. Conversely, XLE has far more room to trend lower in a stagnating low price environment, just as it could outperform a flat, high price oil market for years. That is, as oil prices remain lower for longer the Integrated Companies and E&Ps will shed more and more value, as oil remains flat (and, by extension, USO minus fees). Although XLE may still be better than an individual E&P play in this scenario, the fund’s large dependency on these two segments will send it lower than the 4% maximum loss USO will experience with oil stagnating in the $39-42 range. One of the best shale producers, EOG Resources (representing approximately 4% of XLE’s total investments), even noted that they will not take steps to grow production until oil fully recovers. Thus at this point in time the downside of XLE may exceed the downside of oil itself, in spite of the refiners, pipeline companies, and service companies that partially make up the fund. An investor may be thinking “that’s great, but earlier the idea was that XLE could outperform in a bull market, isn’t that at least true?” Not quite, as the same varying degrees of oil dependence and uniqueness of companies within the fund limit returns the same way they limited weakness. This manifested itself between March 14, 2015 and May 28, 2015 as USO gained 20% and XLE climbed less than 4% over the same period. (click to enlarge) If oil recovers to $50 a barrel then USO would appreciate almost 25%, that same type of performance seems highly unlikely out of XLE as many of the E&Ps need oil prices above $50 over the long-term. While the rally in E&Ps and in the Integrated companies would propel XLE modestly, its diversification would likely again limit returns as depicted in the chart above. Overall, XLE still limits its downside with diversification, but a current investment in it seems akin to catching the proverbial falling knife: the longer oil stays low, the longer its compositions (with exceptions in the downstream, of course) struggle. For a very conservative investor XLE may be the right choice for long-term buy and hold exposure to oil; however, for a trader looking to profit off of an uptick in oil prices XLE is hardly the vehicle to do it with. Disclosure: I am/we are long BP. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
The iShares Exponential Technology ETF Dilutes Exposure With Blue Chips
Summary XT invests in companies developing or using exponential technologies. XT owns many large companies that only have a small exposure to these technologies. Due to blue chip holdings, XT is not as volatile as one might expect from the name, good for conservative investors, but may disappoint those seeking pure plays. The iShares Exponential Technology ETF (NYSEARCA: XT ) seeks to replicate the overall performance, before fees, of the benchmark Morningstar Exponential Technologies Index. This index is comprised of stocks issued by developed and emerging market companies that create and use exponential technologies. Exponential technologies are those which lead to exponential growth, creating entirely new markets where none existed only years before. Most of the companies in this fund use rather than create exponential technologies, which are much rarer. Take a company such as Netflix (NASDAQ: NFLX ), the top holding with 1.22 percent of assets. Netflix uses Internet technology and is riding a wave of technological change, but Netflix didn’t create the technology behind it. Index & Strategy Following the underlying benchmark, XT invests in developed and emerging market companies involved in nine different fields, or themes, which fund managers deem to be “exponential technologies.” These innovative technologies are replacing outdated systems and methodologies. The areas include big data and analytics, bioinformatics, energy and environmental systems, financial services innovation, medicine and neuroscience as well as nanotechnology, networking, robotics and 3-D printing. XT invests at least 80 percent of its assets in securities found in the underlying index. While the fund provides solid exposure to up-and-coming technology companies, such as Illumina (NASDAQ: ILMN ), Splunk (NASDAQ: SPLK ) and Hologic (NASDAQ: HOLX ), it also holds well-established blue chip companies like Airbus (OTCPK: EADSY ), AT&T (NYSE: T ), Boeing (NYSE: BA ), DuPont (NYSE: DD ), Monsanto (NYSE: MON ) and Pfizer (NYSE: PFE ). Those latter firms are unlikely to experience exponential stock price increases because they’re already large blue chip companies. The former firms are more dynamic pure plays on emerging technologies. Illumina develops, manufactures and markets integrated systems that serve the gene expression, sequencing and genotyping industry. Splunk creates software that searches, monitors and analyzes machine-generated big data. Top 10 holding Hologic develops and supplies diagnostic imaging systems related to women’s health. The mix of holdings in XT offers investors the opportunity diversify their portfolios with growth stocks across a wide range of technologies, market caps and geographic locations, but without taking on as much risk as one might expect (and for aggressive investors, want) from a fund with the name “exponential technology.” Index components are scored across individual analysts, sectors and themes. Managers review the scores and collectively select leading candidates for inclusion in the index. Each theme will have one to five leaders. The index is reconstituted annually. At that time, potential candidates for inclusion must have average 3-month trailing daily trading volume in excess of $2 million and a market cap of more than $300 million. Stocks already in the index must have maintained an average 3-month trading volume over $1.5 million and a market cap greater than $200 million. Stocks not meeting these criteria are eliminated from consideration. The remaining qualified candidates are ranked in order of their exposure to exponential technology themes. Managers rank the stocks using specific criteria, such as the number of themes in which the stock is a leader. They also consider the number of themes in which it scores above average and market capitalization with a preference for smaller firms over shares of larger cap names. The 200 highest scoring stocks are included in the index. The ETF’s managers then select and equally weight shares from this index to create the fund’s portfolio. Thus, while XT is technically not an actively managed fund, the selection of components is made by somewhat subjective measures. Portfolio Composition and Holdings XT is a large core growth fund with slightly more than $686 million in assets allocated across 195 individual holdings. The portfolio holds 67 percent of asset in domestic stocks and 31 percent in foreign shares. The fund’s foreign exposure includes Developed and Emerging Europe as well as Developed and Emerging Asia. In addition to the United States, the fund is invested in companies headquartered in the United Kingdom, France, Switzerland and Denmark as well as Canada, Japan, Australia and India. XT holds 27 percent of assets in giant cap stocks along with 40 percent in large caps, 28 percent in mid-cap stocks and 5 percent in small caps. The fund also has a small exposure to micro-cap shares. Compared to the category averages, the ETF is underweight giant caps and overweight large- and mid-cap stocks. XT is heavily weighted towards the technology, health care and telecommunication sectors. The fund’s top 10 holdings comprise 7.9 percent of total assets. These include Netflix , Valeant Pharmaceuticals (NYSE: VRX ), Amazon (NASDAQ: AMZN ), and Seattle Genetics (NASDAQ: SGEN ). While there are many large caps in the portfolio, XT has an average market capitalization of $23.3 billion, which is less than the technology category averages of $40.8 billion. XT shares have a P/E ratio of 20.94 and a price-to-book 2.72. Historical Performance Established in March 2015, XT has generated a 3-month return of 0.26 percent. This compares to the category average of -2.26 percent over the same period. XT has underperformed the Technology Select Sector SPDR ETF (NYSEARCA: XLK ) since inception in March 2015. (click to enlarge) Expenses The fund has a total expense ratio of 0.47 percent, which is less than the category average of 0.57 percent. Dividends Thanks to owning many large blue chips, the fund does pay a dividend. The current 30-day SEC yield is 1.36 percent. Outlook The iShares Exponential Technology Fund provides investors with the opportunity to gain exposure to a niche area of the thriving technology sector. XT is a relatively conservative way to play these companies due to the inclusion of blue chip companies across a range of sectors. Although the fund is equally weighted, its smaller cap components should experience larger gains over the long run. The approach of XT is good for conservative investors if it is successful, but may disappoint aggressive investors looking for pure exposure to innovative, cutting-edge technology companies. Editor’s Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks. Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.